T. Rowe Price Capital Appreciation Adv (PACLX)

Nasdaq • Currently down 0.14 (-0.36%) in today's trading session

1 member of Congress has disclosed 2 trades in T. Rowe Price Capital Appreciation Adv (PACLX) via STOCK Act filings. The most recent disclosure was a purchase by Lois Frankel on 20 December 2023. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

T. Rowe Price Capital Appreciation Adv is currently trading at $38.26, positioned at 95% of its 52-week range ($33.28 – $38.50).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$38.26
24h Change
-0.14 (-0.36%)
52 Week Range
$33.28–$38.50
View on NASDAQ

T. Rowe Price Capital Appreciation Adv Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PACLX

Select to highlight on chart
2 transactions
Compliance: 0%
Lois Frankel20 Dec 20239 Aug 2024PurchaseStock$1,001 - $15,000N/A
Lois Frankel20 Dec 20239 Aug 2024PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$39.42B

Volume

0

Beta

0.80

P/E Ratio

31.84

Fundamentals

EPS

$1.20

Div. Yield

7.99%

Open

$38.40

Day Range

$38.26 – $38.40

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2004-12-30

The fund's core objective is to generate substantial capital growth over an extended period. Typically, it dedicates at least half of its overall portfolio to equity holdings. The remaining assets are generally invested in a variety of debt obligatio...

No earnings data available for this stock.

Dividends

Dividend History

17 Dec 2025
Amount $3.0584
18 Dec 2024
Amount $3.4943
19 Dec 2023
Amount $1.3255
19 Dec 2022
Amount $2.7387
14 Dec 2021
Amount $3.2900
14 Dec 2020
Amount $2.6200
13 Dec 2019
Amount $1.7300
13 Dec 2018
Amount $1.8800
14 Dec 2017
Amount $1.8300
14 Dec 2016
Amount $0.8300
14 Dec 2015
Amount $2.3900
12 Dec 2014
Amount $2.5500
13 Dec 2013
Amount $1.4800
14 Dec 2012
Amount $1.3300
14 Dec 2011
Amount $0.2700
14 Dec 2010
Amount $0.3500
14 Dec 2009
Amount $0.3600
12 Dec 2008
Amount $0.4800
18 Dec 2007
Amount $1.5900
19 Dec 2006
Amount $2.3200
13 Dec 2005
Amount $0.7600

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

PGR

The Progressive Corporation

47
$213.46-9.42 (-4.23%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

MS

Morgan Stanley

47
$181.51-5.13 (-2.75%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

AXP

American Express Company

47
$306.95-2.89 (-0.93%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

Frequently Asked Questions about PACLX

Which members of Congress have traded PACLX?
1 member of Congress has disclosed 2 trade in T. Rowe Price Capital Appreciation Adv (PACLX) under the STOCK Act: Lois Frankel.
When was PACLX most recently disclosed by Congress?
The most recent PACLX disclosure was a purchase by Lois Frankel on 20 December 2023.
What is the total disclosed congressional trading volume for PACLX?
Members of Congress have disclosed approximately $16K in PACLX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PACLX?
This PACLX page updates as soon as new STOCK Act disclosures are filed for T. Rowe Price Capital Appreciation Adv. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.